AVE 33.3% 0.2¢ avecho biotechnology limited

marketing of bodyshaper, page-17

  1. 34,916 Posts.
    lightbulb Created with Sketch. 480
    but that is a head in the sand blind faith position which i dont share.

    Bumpkin, you can call me a lot of things but I can assure you I don't invest in anything with my 'head in the sand'.

    This marketing 'issue' has been discussed ad-nauseum. The marketing plan is clear to me. Australia was the testing pot, it has proven successful, I mean how do YOU measure success. They are about to distribute across Asia via AS Watson. This is a momentous point in the evolution of POH.

    I seriously just don't understand this concern. Maybe it will take hindsight for some to understand what POH have achieved to date. Let's just wait and see. This is a 2-5 year investment from here. People are wanting too much too soon.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.